News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
843,848 Results
Type
Article (86321)
Company Profile (702)
Press Release (756825)
Section
Business (232600)
Career Advice (4125)
Deals (39710)
Drug Delivery (128)
Drug Development (90947)
Employer Resources (198)
FDA (18075)
Job Trends (17319)
News (396292)
Policy (39708)
Tag
2024 BioCapital Digital (20)
2024 BioForest Digital (16)
2024 BioForest Standard (1)
2024 BioMidwest Digital (14)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (19)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (20)
2024 Biotech Beach Digital (15)
2024 Biotech Beach Standard (9)
2024 Genetown Digital (10)
2024 Genetown Standard (12)
2024 Lone Star Bio Digital (17)
2024 Pharm Country Digital (13)
2024 Pharm Country Standard (7)
2025 BioForest Digital (13)
2025 Lone Star Bio Digital (16)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2994)
Academic (2)
Accelerated approval (6)
Adcomms (29)
Allergies (89)
Alliances (56770)
ALS (94)
Alzheimer's disease (1484)
Antibody-drug conjugate (ADC) (143)
Approvals (18042)
Artificial intelligence (303)
Autoimmune disease (24)
Automation (14)
Bankruptcy (404)
Best Places to Work (12633)
BIOSECURE Act (21)
Biosimilars (116)
Biotechnology (481)
Bladder cancer (66)
Brain cancer (31)
Breast cancer (277)
Cancer (2197)
Cardiovascular disease (190)
Career advice (3530)
Career pathing (33)
CAR-T (162)
Cell therapy (462)
Cervical cancer (21)
Clinical research (73155)
Collaboration (848)
Compensation (499)
Complete response letters (30)
COVID-19 (2859)
CRISPR (44)
C-suite (235)
Cystic fibrosis (106)
Data (2060)
Decentralized trials (2)
Denatured (43)
Depression (52)
Diabetes (277)
Diagnostics (6891)
Digital health (20)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (144)
Drug pricing (123)
Drug shortages (33)
Duchenne muscular dystrophy (94)
Earnings (96237)
Editorial (40)
Employer branding (25)
Employer resources (167)
Events (129308)
Executive appointments (702)
FDA (19278)
Featured Employer (64)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (761)
Gene editing (112)
Generative AI (34)
Gene therapy (331)
GLP-1 (829)
Government (5127)
Grass and pollen (5)
Guidances (49)
Healthcare (20882)
Huntington's disease (24)
IgA nephropathy (28)
Immunology and inflammation (132)
Indications (27)
Infectious disease (3012)
Inflammatory bowel disease (148)
Inflation Reduction Act (11)
Influenza (55)
Intellectual property (92)
Interviews (812)
IPO (17796)
IRA (51)
Job creations (5184)
Job search strategy (2861)
Kidney cancer (10)
Labor market (38)
Layoffs (542)
Leadership (21)
Legal (10104)
Liver cancer (76)
Lung cancer (320)
Lymphoma (139)
Machine learning (4)
Management (65)
Manufacturing (317)
MASH (69)
Medical device (14587)
Medtech (14592)
Mergers & acquisitions (22398)
Metabolic disorders (742)
Multiple sclerosis (79)
NASH (23)
Neurodegenerative disease (106)
Neuropsychiatric disorders (31)
Neuroscience (2044)
NextGen: Class of 2025 (7682)
Non-profit (5077)
Northern California (2533)
Now hiring (38)
Obesity (402)
Opinion (271)
Ovarian cancer (76)
Pain (90)
Pancreatic cancer (79)
Parkinson's disease (153)
Partnered (23)
Patents (223)
Patient recruitment (101)
Peanut (51)
People (65104)
Pharmaceutical (143)
Pharmacy benefit managers (21)
Phase I (22565)
Phase II (31760)
Phase III (23947)
Pipeline (1121)
Podcasts (122)
Policy (142)
Postmarket research (3552)
Preclinical (10135)
Press Release (72)
Prostate cancer (100)
Psychedelics (38)
Radiopharmaceuticals (268)
Rare diseases (412)
Real estate (7387)
Recruiting (75)
Regulatory (26668)
Reports (57)
Research institute (2657)
Resumes & cover letters (649)
Rett syndrome (4)
RNA editing (4)
RSV (47)
Schizophrenia (77)
Series A (134)
Series B (85)
Service/supplier (30)
Sickle cell disease (57)
Southern California (2208)
Special edition (18)
Spinal muscular atrophy (166)
Sponsored (33)
Startups (4286)
State (2)
Stomach cancer (16)
Supply chain (70)
Tariffs (15)
The Weekly (77)
United States (23039)
Vaccines (778)
Venture capitalists (39)
Webinars (13)
Weight loss (293)
Women's health (38)
Worklife (19)
Date
Today (84)
Last 7 days (544)
Last 30 days (2763)
Last 365 days (36338)
2025 (9387)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1271)
Alabama (57)
Alaska (7)
Arizona (263)
Arkansas (14)
Asia (49995)
Australia (8814)
California (5905)
Canada (1936)
China (514)
Colorado (264)
Connecticut (285)
Delaware (140)
Europe (114593)
Florida (865)
Georgia (210)
Hawaii (1)
Idaho (64)
Illinois (595)
India (29)
Indiana (319)
Iowa (10)
Japan (150)
Kansas (108)
Kentucky (27)
Louisiana (13)
Maine (70)
Maryland (912)
Massachusetts (4583)
Michigan (238)
Minnesota (404)
Mississippi (2)
Missouri (87)
Montana (31)
Nebraska (26)
Nevada (59)
New Hampshire (69)
New Jersey (1692)
New Mexico (31)
New York (1684)
North Carolina (1083)
North Dakota (8)
Northern California (2533)
Ohio (207)
Oklahoma (15)
Oregon (47)
Pennsylvania (1312)
Puerto Rico (10)
Rhode Island (32)
South America (1650)
South Carolina (19)
South Dakota (1)
Southern California (2208)
Tennessee (98)
Texas (897)
Utah (177)
Virginia (155)
Washington D.C. (66)
Washington State (569)
West Virginia (3)
Wisconsin (63)
There are 843,848 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Tariffs
Trump’s Tariffs Could Challenge Pharma’s Recession-Resistant Reputation
Long considered resistant to economic downturns, the pharmaceutical industry may face a greater challenge this time around as GLP-1s dominate and the population grows older.
April 8, 2025
·
5 min read
·
Annalee Armstrong
Layoff Tracker
Sweeping Layoffs Across Biotech Claim Dozens of Jobs
2024 was a tough year for the biopharma industry, with several companies cutting hundreds or even thousands of employees. Follow along as
BioSpace
tracks job cuts and restructuring initiatives throughout 2025.
April 8, 2025
·
171 min read
·
BioSpace Editorial Staff
Rare diseases
Rallybio Pivots as Antibody for Rare Bleeding Disorder Flunks Dosing Trial
The company is dropping its former lead molecule in favor of another antibody, RLYB116, which is being developed for a variety of rare autoimmune disorders.
April 8, 2025
·
1 min read
·
Dan Samorodnitsky
Press Releases
Psyence BioMed Signs LOI with Southern Star Research to Expand Phase IIb Clinical Trial in Australia
April 8, 2025
·
7 min read
Press Releases
Defence Launches Accum Combined with Actinium-225 to Increase Efficacy and Safety of Radio-Immunoconjugate Cancer Therapies
April 8, 2025
·
4 min read
Press Releases
PlasCred Circular Innovations Inc. Announces Alberta Innovates Funding Grant
April 8, 2025
·
6 min read
Funding
Merida Enters Autoimmune and Allergy Arena With $121M Series A
Merida is working on a selective therapy for Graves’ disease, leveraging targeted therapies that can deplete disease-causing autoantibodies.
April 8, 2025
·
2 min read
·
Tristan Manalac
Government
HHS Leaves Door Open to Future Medicare Coverage of Obesity Drugs
Last week, The Trump administration reversed a Biden-era proposal for Medicare coverage of anti-obesity treatments. But on Monday, HHS suggested it is open to future policy considerations toward this end.
April 8, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Adragos Pharma Expands in Japan: Strengthening Production, Quality, and Trust
April 8, 2025
·
1 min read
Gene therapy
Lexeo Plots Pivotal Path for Friedreich’s Ataxia Gene Therapy After ‘Compelling’ Phase I/II Data
Stifel analysts said that Lexeo’s data showing reduced size and thickness of the heart’s left ventricle are “supportive of a drug effect” for the company’s gene therapy in Friedreich’s ataxia cardiomyopathy.
April 8, 2025
·
2 min read
·
Tristan Manalac
1 of 84,385
Next
